M&A Deal Summary |
|
|---|---|
| Date | 2021-05-28 |
| Target | Polis Fondi |
| Sector | Financial Services |
| Buyer(s) | LBO France |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Asset Manager |
|---|---|
| Founded | 1985 |
| PE ASSETS | 5.4B EUR |
| Size | Mega |
| Type | Sector Agnostic |
LBO France is an independent private equity group focused on acquiring majority stakes in French firms, or companies with French management. LBO France manages several funds, each targeting different types of businesses. The Firm's mid-market fund looks to acquire majority or minority stakes in companies valued from €100 million to €2.5 billion. The mid-market fund generally looks at companies with predictable sales, profits and cash flow, but will also consider businesses with under-utilized assets. LBO France's small cap fund targets majority stakes in smaller, profitable businesses valued from €10 to €100 million, with strong potential for growth or consolidation. In addition to its equity funds, LBO France also invests in real estate and provides LBO loans issued by medium-sized European companies (enterprise value between €150m and €2bn). LBO France was formed in 1985 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 84 of 91 |
| Sector: Financial Services M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 40 of 45 |
| Country: Italy M&A | 5 of 7 |
| Year: 2021 M&A | 2 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-26 |
Hosman
Paris, France Hosman is a neo real estate agency offering an innovative and impeccable service to sell a property online. Hosman has succeeded in becoming the leading online real estate agency that has surpassed 3,000 properties sold (estimated savings on agency fees of €55m) and has won more than 2% of the market in Paris and the surrounding suburbs. Hosman is based in Paris, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-02 |
Voluntis
Suresnes, France Voluntis creates digital therapeutics that empower people with chronic conditions to self-manage their treatment every day, thus improving real-world outcomes. The company's solutions, combining mobile and web apps, use clinical algorithms to deliver personalized recommendations to patients and their care teams. Leveraging its Theraxium technology platform, Voluntis has designed and operates multiple digital therapeutics, especially in oncology and diabetes. It has long-standing partnerships with leading life science companies. Voluntis was formed in 2001 and is based in Cambridge, MA, and Paris, France. |
Sell | - |
